(For treatment side effects and complications only)
Find out more about CCC as a research Sponsor
Every research study that falls within the scope of the Medicines for Human Use (Clinical Trials) Regulations (SI 1031/20/2004), termed ‘the Regulations’ and the UK Policy Framework for Health and Social Care Research v3.2 10/10/2017 termed ‘the Framework’ must have a nominated Research Sponsor.
For studies which fall within the scope of the Regulations the Sponsor is defined as: ‘An individual, company, institution or organisation which takes responsibility for the initiation, management and/or financing of a clinical trial’.
For studies outside the Regulations but within the scope of the Framework a Sponsor is defined as: ‘the individual, or organisation (or group of individuals or organisations) that takes on responsibility for confirming there are proper arrangements to initiate, manage and monitor and finance a study’.
The Clatterbridge Cancer Centre will protect the rights, safety and wellbeing of all participants involved in clinical research and to assure the quality of their care when we act as Sponsor for a research study assuring timely set-up and full research governance and oversight from our RM&G Team and working in partnership with the Liverpool Cancer Trials Unit as preferred service provider.
We will provide all support necessary for the Chief Investigator to develop and then deliver the study. The process has been pared to be as streamlined as possible whilst retaining robust governance and patient safety and wellbeing.